World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0015Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • Chronic mesenteric ischaemia (CMI) is a rare condition, accounting for less than 5% of all intestinal ischaemic events.

  • More than 90% of the cases are due to atherosclerotic occlusion or severe stenosis.

  • Classic symptoms include post-prandial abdominal pain, sitophobia, and weight loss.

  • At least two of the three main splanchnic arteries must be significantly compromised to result in CMI.

  • Duplex ultrasonography is non-invasive and expedient, but may miss up to 20% of vascular lesions in celiac artery.

  • Computed tomography angiography (CTA) and magnetic resonance angiography (MRA) are equally excellent non-invasive modalities with highly accurate diagnosis.

  • Digital Subtraction angiography should be reserved for the diagnosis of CMI only when other modalities have been unhelpful or if intervention such as percutaneous transluminal angioplasty (PTA) is planned.

  • Surgical vascular bypass is the definitive therapy for CMI with an overall 5-year graft patency of 78%. It is preferred in younger patients with less comorbidities.

  • Endovascular therapy is optimal in short segment atherosclerotic lesions <2 cm from the ostia of coeliac and superior mesenteric artery. Angioplasty and stenting have a significantly lower rate of complications although the intervention rate is higher.